Similar companies
| Company | Employee Rating | |
|---|---|---|
 |
AmgenAMGN |
82 0% |
 |
Gilead SciencesGILD |
76 0% |
 |
Catalyst PharmaceuticalsCPRX |
80 0% |
 |
Inovio PharmaceuticalsINO |
64 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Do employees enjoy working at Crispr Therapeutics?
Working at Crispr Therapeutics is ok, according to employees. The average rating, aggregated from the top review sites in the US, of 66 out of 100 is decent.
Analyzing Employee Rating, how is Crispr Therapeutics performing compared to its industry peers?
Crispr Therapeutics overperforms a majority of its industry peers when it comes to Employee Rating, ranking in the 66th percentile.
Why should investors track Crispr Therapeutics' employee ratings?
Investors should monitor Crispr Therapeutics' employee ratings as they offer insights into the company's internal health and culture. High ratings often correlate with employee satisfaction and retention, which can lead to increased productivity, innovation, and ultimately, better financial performance. Conversely, low ratings might signal internal issues that could impact the company's future performance.
How often is Crispr Therapeutics' employee rating updated?
AltIndex updates Crispr Therapeutics' employee ratings every month. This regular update schedule ensures that investors have access to the latest information, reflecting any recent changes in employee sentiment or internal company dynamics.
Sign up and get more insights on Crispr Therapeutics.
